Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events
Abstract
UNLABELLED: Nonalcoholic steatohepatitis (NASH) is an independent predictor of coronary artery disease (CAD). Our aim was to compare the incidence of cardiovascular (CV) events between patients transplanted for NASH and alcohol (ETOH)-induced cirrhosis. This is a retrospective cohort study (August 1993 to March 2010) of 242 patients (115 NASH and 127 ETOH) with ≥12 months follow-up after liver transplantation (LT). Those with hepatocellular carcinoma or coexisting liver diseases were excluded. Kaplan-Meier's and Cox's proportional hazard analyses were conducted to compare survival. Logistic regression was used to calculate the likelihood of CV events, defined as death from any cardiac cause, myocardial infarction, acute heart failure, cardiac arrest, arrhythmia, complete heart block, and/or stroke requiring hospitalization <1 year after LT. Patients in the NASH group were older (58.4 versus 53.3 years) and were more likely to be female (45% versus 18%; P < 0.001). They were more likely to be morbidly obese (32% versus 9%), have dyslipidemia (25% versus 6%), or have hypertension (53% versus 38%; P < 0.01). On multivariate analysis, NASH patients were more likely to have a CV event <1 year after LT, compared to ETOH patients, even after controlling for recipient age, sex, smoking status, pretransplant diabetes, CV disease, and the presence of metabolic syndrome (26% versus 8%; odds ratio = 4.12; 95% confidence interval = 1.91-8.90). The majority (70%) of events occurred in the perioperative period, and the occurrence of a CV event was associated with a 50% overall mortality. However, there were no differences in patient, graft, or CV mortality between groups. CONCLUSIONS: CV complications are common after LT, and NASH patients are at increased risk independent of traditional cardiac risk factors, though this did not affect overall mortality.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The risk of major (including fatal) cardiovascular events appears to be particularly high in the first year after transplantation, especially in the perioperative period.
“The risk of major (including fatal) cardiovascular events appears to be particularly high in the fi rst year after transplantation, especially in the perioperative period. 485”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [485]
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198 · see citing works
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907 · see citing works
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander‐Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,155 · see citing works
Obesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806 · see citing works
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
Mangano, D. T., Layug, E. L., Wallace, A. W., & Tateo, I. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612053352301 · Cited by 1,683 · see citing works
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Tessari, R., Zenari, L., Day, C. P., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc06-2247 · Cited by 990 · see citing works
Murray, K. F., & Carithers, R. L. (2005) · Hepatology · doi:10.1002/hep.20704 · Cited by 933 · see citing works
Perioperative Beta-Blocker Therapy and Mortality after Major Noncardiac Surgery
Lindenauer, P. K., Pekow, P. S., Wang, K., Mamidi, D. K., Gutiérrez, B., & Benjamin, E. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041895 · Cited by 855 · see citing works
Poldermans, D., Bax, J. J., Boersma, E. H., Hert, S. G. D., Eeckhout, E., Fowkes, G. R., Görenek, B., Hennerici, M. G., Iung, B., Kelm, M., et al. (2010) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e328334c017 · Cited by 675 · see citing works
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 627 · see citing works
Sanyal, A. J., Banas, C. A., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Heuman, D. M., COTTERELL, A. H., Fisher, R. A., et al. (2006) · Hepatology · doi:10.1002/hep.21103 · Cited by 521 · see citing works
Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469 · see citing works
Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
Chalasani, N., Aljadhey, H., Kesterson, J., Murray, M. D., & Hall, S. D. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.015 · Cited by 441 · see citing works
Pleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction?
Robinson, J. G., Smith, B., Maheshwari, N., & Schrott, H. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.085 · Cited by 407 · see citing works
Bernardi, M., Calandra, S., Colantoni, A., Trevisani, F., Raimondo, M. L., Sica, G. S., Schepis, F., Mandini, M., Simoni, P., Contin, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270106 · Cited by 393 · see citing works
Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease
Møller, S., & Henriksen, J. H. (2002) · Heart · doi:10.1136/heart.87.1.9 · Cited by 372 · see citing works
Nonalcoholic fatty liver disease: A review of current understanding and future impact
Charlton, M. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00440-9 · Cited by 350 · see citing works
Møller, S., & Henriksen, J. H. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.023 · Cited by 342 · see citing works
Laryea, M. A., Watt, K. D. S., Molinari, M., Walsh, M. J., McAlister, V. C., Marotta, P. J., Nashan, B., & Peltekian, K. M. (2007) · Liver Transplantation · doi:10.1002/lt.21126 · Cited by 316 · see citing works
Lewis, J. H., Mortensen, M. E., Zweig, S., Fusco, M. J., Medoff, J. R., & Belder, R. (2007) · Hepatology · doi:10.1002/hep.21848 · Cited by 305 · see citing works
QT prolongation and sudden cardiac death in patients with alcoholic liver disease
Campbell, R. W. F., Day, C. P., James, O., & Butler, T. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90879-l · Cited by 254 · see citing works
Plotkin, J. S., Scott, V. L., Pinna, A., et al. (1996) · Liver Transplantation and Surgery · doi:10.1002/lt.500020604 · Cited by 251 · see citing works
Bosch, J., Abraldeṣ, J. G., Fernández, M., & García‐Pagán, J. C. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.021 · Cited by 224 · see citing works
Ioannou, G. N., Weiss, N. S., Boyko, E. J., Mozaffarian, D., & Lee, S. P. (2006) · Hepatology · doi:10.1002/hep.21171 · Cited by 220 · see citing works
Outcome After Liver Transplantation for NASH Cirrhosis
Malik, S. M., DeVera, M., Fontes, P., Shaikh, O. S., & Ahmad, J. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02590.x · Cited by 206 · see citing works
Cumulative Risk of Cardiovascular Events After Orthotopic Liver Transplantation
Albeldawi, M. J., Aggarwal, A., Madhwal, S., Cywiński, J. B., López, R., Eghtesad, B., & Zein, N. N. (2011) · Liver Transplantation · doi:10.1002/lt.22468 · Cited by 197 · see citing works
Cirrhotic cardiomyopathy and liver transplantation
Myers, R. P., & Lee, S. S. (2000) · Liver Transplantation · doi:10.1002/lt.500060510 · Cited by 189 · see citing works
Mohamed, R., Forsey, P., Davies, M. K., et al. (1996) · Hepatology · doi:10.1002/hep.510230529 · Cited by 184 · see citing works
Bhagat, V., Mindikoglu, A. L., Nudo, C. G., Schiff, E. R., Tzakis, A. G., & Regev, A. (2009) · Liver Transplantation · doi:10.1002/lt.21927 · Cited by 181 · see citing works
Cardiac morbidity and mortality related to orthotopic liver transplantation
Therapondos, G., Flapan, A. D., Plevris, J. N., & Hayes, P. C. (2004) · Liver Transplantation · doi:10.1002/lt.20298 · Cited by 165 · see citing works
Safadi, A., Homsi, M., Maskoun, W., Lane, K. A., Singh, I. M., Sawada, S. G., & Mahenthiran, J. (2009) · Circulation · doi:10.1161/circulationaha.108.847178 · Cited by 159 · see citing works
Chronic Hepatitis C and Type II Diabetes Mellitus: A Prospective Cross-Sectional Study
Zein, C. O., Levy, C., Basu, A., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40429.x · Cited by 146 · see citing works
Sonographic fatty liver, overweight and ischemic heart disease
Lin, Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i31.4838 · Cited by 141 · see citing works
Anesthesia for Patients with Congenital Long QT Syndrome
Kies, S. J., Pabelick, C. M., Hurley, H. A., White, R. D., & Ackerman, M. J. (2004) · Anesthesiology · doi:10.1097/00000542-200501000-00029 · Cited by 137 · see citing works
Umphrey, L. G., Hurst, R. T., Eleid, M. F., et al. (2008) · Liver Transplantation · doi:10.1002/lt.21495 · Cited by 113 · see citing works
Alkhouri, N., Tamimi, T., Yerian, L. M., López, R., Zein, N. N., & Feldstein, A. E. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1075-y · Cited by 113 · see citing works
Diagnosis and Therapy of Alcoholic Liver Disease
Levitsky, J., & Mailliard, M. E. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-832937 · Cited by 110 · see citing works
A meta-analysis of perioperative beta blockade: What is the actual risk reduction?
McGory, M. L., Maggard, M. A., & Ko, C. Y. (2005) · Surgery · doi:10.1016/j.surg.2005.03.022 · Cited by 109 · see citing works
Causes of death in autopsied liver transplantation patients.
Torbenson, M. S., Wang, J., Nichols, L., et al. (1998) · PubMed · Cited by 78 · see citing works
QT PROLONGATION AND NEAR FATAL CARDIAC ARRHYTHMIA AFTER INTRAVENOUS TACROLIMUS ADMINISTRATION
Hodak, S. P., Moubarak, J. B., Rodríguez, I., Gelfand, M. C., Alijani, M. R., & Tracy, C. M. (1998) · Transplantation · doi:10.1097/00007890-199808270-00021 · Cited by 78 · see citing works
Tsutsui, J. M., Mukherjee, S., Elhendy, A. A., et al. (2006) · Liver Transplantation · doi:10.1002/lt.20651 · Cited by 48 · see citing works
Guckelberger, O., Byram, A. O., Klupp, J., et al. (2005) · Transplant International · doi:10.1111/j.1432-2277.2005.00174.x · Cited by 47 · see citing works
Alterations in QT Interval in Patients Undergoing Living Donor Liver Transplantation
Shin, W., Kim, Y., Song, J., et al. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.12.002 · Cited by 44 · see citing works
Patients with Metabolic Syndrome Have Prolonged Corrected QT Interval (QTc)
Li, W., Bai, Y., Sun, K., et al. (2009) · Clinical Cardiology · doi:10.1002/clc.20416 · Cited by 43 · see citing works
The association of the metabolic syndrome with QTc interval in NHANES III
Faramawi, M. F., Wildman, R. P., Gustat, J., Rice, J. C., & Kareem, M. Y. A. (2008) · European Journal of Epidemiology · doi:10.1007/s10654-008-9252-4 · Cited by 25 · see citing works
Perioperative use of statins in noncardiac surgery
Chan, Y. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.75 · Cited by 21 · see citing works
Perioperative use of statins in noncardiac surgery
Chan, Y. C. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1915 · Cited by 13 · see citing works
Statin Therapy in the Perioperative Period
Lander, J. S., & Coplan, N. L. (2011) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0552 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210 · see citing works
Non‐alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management
Huang, T. (., Behary, J., & Zekry, A. (2020) · Internal Medicine Journal · doi:10.1111/imj.14709 · Cited by 227 · see citing works
VanWagner, L. B., Serper, M., Kang, R., Levitsky, J., Hohmann, S., Abecassis, M., Skaro, A., & Lloyd-Jones, D. M. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13779 · Cited by 180 · see citing works
Self-citationDonor-derived cell-free DNA levels predict graft injury in liver transplant recipients
Levitsky, J., Kandpal, M., Guo, K., Kleiboeker, S., Sinha, R., & Abecassis, M. (2022) · American Journal of Transplantation · doi:10.1111/ajt.16835 · Cited by 102 · see citing works
Tsochatzis, E., Coilly, A., Nadalin, S., Levistky, J., Tokat, Y., Ghobrial, M., Klinck, J., & Berenguer, M. (2019) · Transplantation · doi:10.1097/tp.0000000000002433 · Cited by 105 · see citing works
Management of metabolic syndrome and cardiovascular risk after liver transplantation
Fatourou, E. M., & Tsochatzis, E. A. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30181-5 · Cited by 59 · see citing works
Authors, & Collaborators: (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1880-2388 · Cited by 30 · see citing works
Zhou, G.-P., Jiang, Y.-Z., Sun, L.-Y., & Zhu, Z.-J. (2022) · International Journal of Surgery · doi:10.1016/j.ijsu.2022.106752 · Cited by 10 · see citing works
Sharma, S., Stine, J. G., Verbeek, T., & Bezinover, D. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.07.020 · Cited by 5 · see citing works
- Authors
- VanWagner, L. B., Bhave, M., Te, H. S., Feinglass, J., Alvarez, L., & Rinella, M. E.
- Affiliations
- Northwestern University (US)
- University of Chicago (US)
- Corresponding author
- Rinella, Mary E.
- Venue
- Hepatology
- Published
- 2012-11
- Volume
- 56
- Issue
- 5
- Pages
- 1741-1750
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1992212357
- Cited by
- 220
- References
- 49
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 13 · 2023: 12 · 2022: 16 · 2021: 20 · 2020: 20 · 2019: 28 · 2018: 17 · 2017: 20 · 2016: 19 · 2015: 21 · 2014: 15 · 2013: 8 · 2012: 1
- FWCI
- 14.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- nonalcoholic steatohepatitis, liver transplantation, postoperative cardiovascular events, alcoholic cirrhosis, coronary artery disease, perioperative cardiac complications, metabolic syndrome, graft survival
- MeSH terms
- Aged, Arrhythmias, Cardiac, Cardiovascular Diseases, Fatty Liver, Female, Heart Arrest, Heart Block, Heart Failure, Hospitalization, Humans, Hypertension, Liver Cirrhosis, Alcoholic, Male, Middle Aged, Myocardial Infarction, Obesity, Morbid, Retrospective Studies, Risk Factors, Incidence, Logistic Models, Proportional Hazards Models, Liver Transplantation, Stroke, Dyslipidemias, Kaplan-Meier Estimate, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review